What Is Exemestane? Dosage, Half-Life & How to Track It

What exemestane is and how it works

Aromatase converts androgens into estrogen throughout the body, and exemestane is structurally a modified androgen (an androstenedione analog) that binds directly to aromatase’s active site and permanently inactivates it — a so-called “suicide inhibitor.” That’s a different mechanism from anastrozole or letrozole, which occupy the same site reversibly and only block the enzyme while the drug is actually present.

Because the binding is irreversible, the body has to synthesize entirely new aromatase enzyme molecules to restore activity, rather than simply clearing the drug from the bloodstream. FDA approval covers breast cancer, specifically as sequential therapy after tamoxifen (a SERM) — using exemestane after another aromatase inhibitor is off-label practice, not the FDA-labeled indication. Off-label, some TRT/AAS users prefer exemestane specifically because its steroidal structure and mildly androgenic metabolite have been associated with a less negative lipid impact than the non-steroidal AIs in some comparative studies — worth confirming with your own labs rather than assuming it applies to you.

Dosing & the tablet math

The FDA dose is 25 mg once daily, with food (food meaningfully increases absorption). Off-label TRT/AAS doses are typically a fraction of that, since the oncology target is near-complete (~98%) aromatase suppression, while managing estrogen from a TRT or AAS protocol is a much smaller aromatization load.

Exemestane tablets aren’t reliably scored for quarters, so a pill splitter and consistent technique matter more than they might seem to.

An uneven quarter tablet is an uneven aromatase-inactivation dose that day — since the effect is irreversible per dose, consistency in the split matters more here than with a reversible AI you can simply take again tomorrow.

Half-life & what it means for frequency

Exemestane’s plasma half-life is short — around 24 hours — shorter than anastrozole’s or letrozole’s, which on its own would suggest needing more frequent dosing to keep constant blood levels. But because the binding to aromatase is irreversible, the enzyme stays inactivated after the drug itself has cleared; effect outlasts plasma presence. That’s a large part of why every-other-day or a few-times-weekly schedules are common in off-label use despite the short half-life.

That same lag cuts against reacting too quickly: because inactivated enzyme has to be replaced by fresh synthesis regardless of how much drug is currently in the blood, raising the dose immediately after one “still elevated” estradiol reading risks over-correcting once the new enzyme turnover and the new dose both catch up.

What to track & side effects

Worth monitoring: estradiol, a lipid panel (the comparative advantage some cite for exemestane, worth verifying against your own numbers), joint symptoms, mood, and libido — the same core panel as any aromatase inhibitor.

The over-suppression risk is the same as any AI: joint pain, low libido, and — with prolonged heavy use — reduced bone density if estradiol runs too low for too long. Because exemestane has a mildly androgenic metabolite (17-hydroxyexemestane), some people report it “feels” different from a pure estrogen-blocker; that’s anecdotal and not a substitute for a lab-confirmed estradiol trend.

Frequently asked questions